Biologic disease-modifying antirheumatic drugs (bDMARDs) do not appear to negatively impact fertility among women with rheumatoid arthritis (RA) or psoriatic arthritis (PsA), according to study ...

Rheumatoid arthritis is an autoimmune condition that causes the bodys immune system to attack the joints causing pain ...

Stopping glucagon-like peptide-1 receptor agonist (GLP-1 RA) treatment 14 days before total joint arthroplasty can minimize ...

Rheumatoid arthritis neuropathy occurs when inflammation or other factors related to RA affect the peripheral nervous system.

The interleukin (IL)-1 antagonist, anakinra, was also approved for the treatment of RA, but is not commonly used because of the low efficacy of this agent. Approved in some parts of the world ...

Janus kinase inhibitor cycling may be more effective than switching to bDMARDs among patients with RA who had an inadequate response to initial JAK inhibitor therapy.

Groundbreaking research reveals how gut health could reshape rheumatoid arthritis treatment offering new hope for symptom ...

Filgotinib maintained a favorable safety and efficacy profile for up to 8 years among patients with RA who participated in the DARWIN 3 LTE.